Previous Article | Next Article ![]()
Infect. Immun., 10 1997, 4055-4060, Vol 65, No. 10
N Garg, M Postan, K Mensa-Wilmot and RL Tarleton
Induction of a glycosylphosphatidylinositol (GPI) deficiency in Trypanosoma
cruzi by the heterologous expression of Trypanosoma brucei
GPI-phospholipase C (GPI-PLC) results in decreased expression of major
surface proteins (N. Garg, R. L. Tarleton, and K. Mensa-Wilmot, J. Biol.
Chem. 272:12482-12491, 1997). To further explore the consequences of a GPI
deficiency on replication and differentiation of T. cruzi, the in vitro and
in vivo behaviors of GPI-PLC-expressing T. cruzi were studied. In
comparison to wild-type controls, GPI-deficient T. cruzi epimastigotes
exhibited a slight decrease in overall growth potential in culture. In the
stationary phase of in vitro growth, GPI-deficient epimastigotes readily
converted to metacyclic trypomastigotes and efficiently infected mammalian
cells. However, upon conversion to amastigote forms within these host
cells, the GPI-deficient parasites exhibited a limited capacity to
replicate and subsequently failed to differentiate into trypomastigotes.
Mice infected with GPI-deficient parasites showed a substantially lower
rate of mortality, decreased tissue parasite burden, and a moderate tissue
inflammatory response in comparison to those of mice infected with
wild-type parasites. The decreased virulence exhibited by GPI-deficient
parasites suggests that inhibition of GPI biosynthesis is a feasible
strategy for chemotherapy of infections by T. cruzi and possibly other
intracellular protozoan parasites.
Copyright © 1997, American Society for Microbiology
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes
Department of Cellular Biology, University of Georgia, Athens 30602, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|